Navigation Links
Oral Transmucosal Drug Delivery. Products, Players, Markets & Forecasts
Date:3/19/2013

DUBLIN, Ireland, March 19, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Oral Transmucosal Drug Delivery. Products, Players, Markets & Forecasts" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2015 as buccal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.

Highlights:

- Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market

- Analyzes oral transmucosal drug products and pipeline product candidates

- Provides assessments of key oral transmucosal drug therapeutic categories

- Provides market data and forecasts to 2016

- Profiles market participants, their product development activities and strategies

Key Topics Covered:

- Executive Summary
- Drug Delivery Market Dynamics
- Competing Transmucosal Delivery Technologies
- Commercial Transmucosal Formulation Platforms
- Oral Transmucosal Drug Technology Factors
- FDA-Approved Oral Transmucosal Products
- Important Pipeline Product Candidates
- Market Assessments & Forecasts
- Market Factors
- Market Participant Profiles

For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/ltg5xz/oral_transmucosal

Research and Markets
Laura Wood , Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +1-353-1-481-1716
Sector: Drug Delivery



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
2. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
3. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
4. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
5. BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
6. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
7. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
8. Perrigo Company To Acquire Assets Of Sergeants Pet Care Products, Inc., For $285 Million
9. Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities
10. China Biologic Products, Inc. Adopts Stockholder Rights Plan
11. Wright Therapy Products, Inc. Closes $3 million Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... DIEGO and SEOUL, South ... Silicon Biosys­tems Menarini and Macrogen, Inc. today announced ... assays and innovative procedures for precision medicine in ... combine Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s ... of tests certified under the Clinical Laboratory Improvement ...
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... -- Stem cells are primitive cells found in all ... capacity to differentiate into mature cell types Stem cells ... mouse embryonic stem cells were derived from embryos in ... first culturing of embryonic stem cells from non-human primates ... 2006 As a result of these discoveries, stem cells ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... Fisher House Foundation ... Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns ... the VA Southern Nevada Healthcare System. This will be the first Fisher House ...
(Date:2/12/2016)... ... 2016 , ... Young Asset Protection, a full service insurance ... latest charity campaign in their community enrichment program. Art Expression utilizes after-school programs ... are currently being accepted at: http://artexpressioninc.org/ . , Art Expression is a ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... , The print component of “Revolutionizing Cancer Care” is distributed within ... Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 copies and an ...
(Date:2/12/2016)... ... 2016 , ... A lot has been reported about the fitness routines of ... health and wellness resources most Americans could ever dream of having at their disposal. ... as frenetic as the U.S. President. , In honor of President’s Day on ...
(Date:2/12/2016)... ... , ... Basketball is a game for everyone, not just those who can ... language translation is featured in the top right of the screen. Every technique that ... a sign language translator to teach kids the game and how to be as ...
Breaking Medicine News(10 mins):